{"id":547276,"date":"2010-04-29T17:30:27","date_gmt":"2010-04-29T21:30:27","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=76753"},"modified":"2010-04-29T17:30:27","modified_gmt":"2010-04-29T21:30:27","slug":"bill-gates-backs-schrodinger","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/547276","title":{"rendered":"Bill Gates Backs Schr\u00f6dinger"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/deals\/\">deals<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/Software\/\">Software<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/Drugs\/\">Drugs<\/a><\/div>\n<p>\t\t<strong>Gregory T. Huang wrote:<\/strong><\/p>\n<p>Schr\u00f6dinger, a New York and Portland, OR-based maker of chemical-simulation software for drug development and research, <a href=\"http:\/\/www.schrodinger.com\/news\/48\/\">has received<\/a> a $10 million equity investment from Bill Gates through Cascade Investment, Gates&#8217;s private investment and holding company. The news was reported earlier today by the <a href=\"http:\/\/online.wsj.com\/article_email\/SB10001424052748703648304575212431415129588-lMyQjAxMTAwMDIwODEyNDgyWj.html\">Wall Street Journal<\/a>. The money will be used to support R&#038;D projects to advance the state of the art in computer-aided drug design. Schr\u00f6dinger (love the name) says its software &#8220;has been used by nearly every major pharmaceutical firm worldwide as well as hundreds of smaller firms and academic and government research laboratories.&#8221; The company was founded in 1990.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/seattle\/2010\/04\/29\/bill-gates-backs-schrodinger\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20Bill%20Gates%20Backs%20Schrdinger%20http:\/\/xconomy.com\/?p=76753\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/seattle\/2010\/04\/29\/bill-gates-backs-schrodinger\/&#038;t=Bill%20Gates%20Backs%20Schrdinger\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/seattle\/2010\/04\/29\/bill-gates-backs-schrodinger\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=Bill+Gates+Backs+Schr%C3%B6dinger&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fseattle%2F2010%2F04%2F29%2Fbill-gates-backs-schrodinger%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>UNDERWRITERS AND PARTNERS<br \/>\n\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 51\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d.xconomy.com\/ck.php?bannerid=51' ><br \/>\n\t\t\t\t<img src='http:\/\/d.xconomy.com\/avw.php?bannerid=51&amp;cb=1' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 14\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d.xconomy.com\/ck.php?bannerid=14' ><br \/>\n\t\t\t\t<img src='http:\/\/d.xconomy.com\/avw.php?bannerid=14&amp;cb=496' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 66\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d.xconomy.com\/ck.php?bannerid=66' ><br \/>\n\t\t\t\t<img src='http:\/\/d.xconomy.com\/avw.php?bannerid=66&amp;cb=139' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 6\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d.xconomy.com\/ck.php?bannerid=6' ><br \/>\n\t\t\t\t<img src='http:\/\/d.xconomy.com\/avw.php?bannerid=6&amp;cb=849' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 98\n    [1] => 108\n    [2] => 80\n    [3] => 78\n    [4] => 101\n    [5] => 114\n    [6] => 82\n    [7] => 112\n    [8] => 253\n    [9] => 110\n    [10] => 249\n    [11] => 105\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d.xconomy.com\/ck.php?bannerid=98' ><br \/>\n\t\t\t\t<img src='http:\/\/d.xconomy.com\/avw.php?bannerid=98&amp;cb=900' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 169\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d.xconomy.com\/ck.php?bannerid=169' ><br \/>\n\t\t\t\t<img src='http:\/\/d.xconomy.com\/avw.php?bannerid=169&amp;cb=62' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 76\n    [1] => 74\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d.xconomy.com\/ck.php?bannerid=76' ><br \/>\n\t\t\t\t<img src='http:\/\/d.xconomy.com\/avw.php?bannerid=76&amp;cb=34' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t\t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=617ddfbcf03985a92ca80ee83395a1d8&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=617ddfbcf03985a92ca80ee83395a1d8&#038;p=1\"\/><\/a><br \/>\n<img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" style=\"display:none\" src=\"http:\/\/ib.adnxs.com\/seg?add=24595&#038;t=2\"\/><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/5GrvCAevqxbCXaYL-eROTvrAQac\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/5GrvCAevqxbCXaYL-eROTvrAQac\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/5GrvCAevqxbCXaYL-eROTvrAQac\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/5GrvCAevqxbCXaYL-eROTvrAQac\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/Eb43l37HYFs\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>deals, Software, Drugs Gregory T. Huang wrote: Schr\u00f6dinger, a New York and Portland, OR-based maker of chemical-simulation software for drug development and research, has received a $10 million equity investment from Bill Gates through Cascade Investment, Gates&#8217;s private investment and holding company. The news was reported earlier today by the Wall Street Journal. The money [&hellip;]<\/p>\n","protected":false},"author":1747,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,10],"tags":[],"class_list":["post-547276","post","type-post","status-publish","format-standard","hentry","category-news","category-software"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/547276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1747"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=547276"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/547276\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=547276"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=547276"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=547276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}